IL1B and major depressive disorder: Indeed, depression treatment significantly decreases the levels of some cytokines, including IL-1 [25], and treatment with anti-inflammatory substances, such as minocycline or N-acetyl cysteine (NAC) [22], may improve clinical outcomes in depression.